期刊文献+

稳定的水溶性Fe_3O_4纳米粒子的制备及其表征 被引量:1

Synthesis and characterization of stable water-soluble Fe_3O_4 nanoparticles
下载PDF
导出
摘要 目的:制备稳定的水溶性Fe3O4纳米粒子(PMAT-Fe3O4)磁共振成像(MRI)造影剂,并对合成的粒子进行表征。方法:利用高分子聚-1-十四碳烯-马来酸酐(PMAT)修饰油溶性Fe3O4纳米粒子表面,使粒子表面富含亲水性羧基基团,使粒子能够稳定存在于水相中,并用透射电镜(TEM)、动态光散射(DLS)、振动样品磁强计(VSM)、傅立叶红外吸收光谱(FT-IR)和MRI等方法进行表征。结果:(1)TEM分析显示,PMAT-Fe3O4粒子直径约为10 nm,DLS测定其水动力学平均直径约为80 nm;(2)PMAT-Fe3O4粒子能稳定分散于去离子水、PBS、Tris、MES等缓冲液中,不发生团聚;(3)VSM、MRI等分析手段显示,PMAT-Fe3O4的饱和磁化强度Ms≈14.0 emu.g-1,弛豫率r2=367.79 mM-1s-1。结论:PMAT-Fe3O4具有良好的水溶性、磁学性能和较高的r2值,有望发展成为一种性能优异的MRI造影剂。 Objective: To synthesize stable and water-soluble PMAT-Fe3O4 nanoparticles(NPs) as MRI contrast agent and characterize it.Methods: Poly maleic anhydride alt-1-tetradecene(PMAT) was utilized to modify the surface of oil-soluble NPs,and the obtained PMAT-Fe3O4 NPs were characterized by TEM,DLS,FT-IR,VSM and MRI.Results:(1) TEM and DLS studies showed that the PMAT-Fe3O4 NPs have a magnetic core size of about 10 nm and a hydrodynamic diameter of about 80 nm.(2) PMAT-Fe3O4 could keep stable in water and familiar buffers,such as MES,PBS and Tris without aggregation.(3) VSM measurements showed that the saturation magnetization(Ms) was about 14.0 emu·g-1,the relaxivity value(r2) of PMAT-Fe3O4 was 367.79 mM-1s-1.Conclusion: The obtained PMAT-Fe3O4 NPs possess outstanding water-solubility,good magnetic properties,and high r2 value,which are therefore expected to become an excellent MRI contrast agent.
出处 《东南大学学报(医学版)》 CAS 2010年第2期127-132,共6页 Journal of Southeast University(Medical Science Edition)
基金 国家自然科学基金资助项目(NOs:30870679 30970787) 国家基础研究项目(NOs:2006CB933206 2006CB705606)
关键词 FE3O4纳米粒子 表面修饰 聚合物 弛豫率 Fe3O4 nanoparticles surface modification polymer relaxivity
  • 相关文献

参考文献19

  • 1JUN Y W,LEE J H,CHEON J.Chemical design of nanoparticle probes for high-performance magnetic resonance imaging[J].Angsw Chem Int Ed Engl,2008,47(28):5122-5135.
  • 2SUNG J C,BENJAMIN R J,ANGELIQUE Y L,et al.Gold-coated iron nanoparticles:a novel magnetic resonance agent for T1 and T2 weighted imaging[J].Nanotechnology,2006,17(3):640-644.
  • 3BILLOTEY C,WILHELM C,DEVAUD M,et al.Cell internalization of anionic maghemite nanoparticles:Quantitative effect on magnetic resonance imaging[J].Magn Reson Med,2003,49(4):646-654.
  • 4JA Y P,EUN S C,MYUNG J B,et al.Water-soluble ultra small paramagnetic or superparamagnetic metal oxide nanoparticles for molecular MR imaging[J].Eur J Inorg Chem,2009,17:2477-2481.
  • 5LAN Q,LIU C,YANG F,et al.Synthesis of bilayeroleic acid-coated Fe3O4 nanoparticles and their application in pH-responsive pickering emulsions[J].Colloid and Interface Science,2007,310(1):260-269.
  • 6姜健.分光光度法测定自来水中的铁含量[J].辽宁化工,2005,34(4):183-184. 被引量:8
  • 7杨瑞成,郧栋,穆元春.纳米Fe3O4磁流体的制备及表征[J].兰州理工大学学报,2008,34(1):22-25. 被引量:14
  • 8PEDRO T,CARLOS J S.Synthesis of Monodisperse superparamagnetic Fe/Silica nanospherical composites[J].Am Chem Soc,2003,125(51):15754-15755.
  • 9LU H C,Yi G S,ZHAO S Y,et al.Synthesis and characterization of multi-functional nanoparticles possessing magnetic,up-conversion fluorescence and bio-affinity properties[J].Mater Chem,2004,14:1336-1341.
  • 10杨玉东,于忠淇,潘卫三,梁勇.超顺磁性造影剂的研究进展[J].现代生物医学进展,2007,7(9):1387-1390. 被引量:7

二级参考文献45

共引文献35

同被引文献11

  • 1梅晓亮,赵建宁.深静脉血栓形成与炎性因子相关性研究进展[J].医学研究生学报,2011,24(5):558-560. 被引量:31
  • 2Spuentrup E,Katoh M,Wiethoff AJ,et al.Molecular coronary MR imaging of human thrombi using EP-2104R,a fibrin-targeted contrast agent:experimental study in a swine model[J].Rofo,2007,179(11):1166-1173.
  • 3Liu J,Sun Z,Deng Y,et al.Highly water-dispersible biocompatible magnetite particles with low cytotoxicity stabilized by citrate groups[J].Angew Chem Int Ed English,2009,48(32):5875-5879.
  • 4Teng Z,Zhu X,Zheng G,et al.Ligand exchange triggered controlled-release delivery system base on superparamagnetic mesoporous silica spheres[J].J Mater Chem,2012,22(34):17677-17684.
  • 5Lu Z,Qin Y,Fang J,et al.Monodisperse magnetizable silica composite particles from heteroaggregate of carboxylic polystyrene latex and Fe3O4 nanoparticles[J].Nanotechnology,2008,19(5):550-602.
  • 6Spuentrup E,Katoh M,Buecker A,et al.Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent[J].Invest Radiol,2007,42(8):586-595.
  • 7Spuentrup E,Katoh M,Wiethoff AJ,et al.Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent[J].Am J Respir Crit Care Med,2005,172(4):494-500.
  • 8Spuentrup E,Buecker A,Katoh M,et al.Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent[J].Circulation,2005,111(11):1377-1382.
  • 9von zur Muhlen C,Peter K,Ali ZA,et al.Visualization of Activated Platelets by Targeted Magnetic Resonance Imaging Utilizing Conformation-Specific Antibodies against Glycoprotein IIb/IIIa[J].J Vasc Res,2009,46(1):6-14.
  • 10Aruva MR,Daviau J,Sharma SS,et al.Imaging thromboembolism with fibrin-avid 99mTc-peptide:evaluation in swineswine[J].J Nucl Med,2006,37(1):155-162.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部